Abbott India Limited
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, … Read more
Abbott India Limited (ABBOTINDIA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.130x
Based on the latest financial reports, Abbott India Limited (ABBOTINDIA) has a cash flow conversion efficiency ratio of 0.130x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹5.22 Billion) by net assets (₹40.11 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Abbott India Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Abbott India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Abbott India Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Abbott India Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Scatec Solar OL
OL:SCATC
|
0.046x |
|
Veritex Holdings Inc
NASDAQ:VBTX
|
0.017x |
|
Zhejiang Dingli Mach Co Ltd
SHG:603338
|
0.032x |
|
Dalmia Bharat Limited
NSE:DALBHARAT
|
0.041x |
|
Douglas Emmett Inc
NYSE:DEI
|
0.032x |
|
Hillman Solutions Corp
NASDAQ:HLMN
|
0.021x |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
0.055x |
|
Deutz AG
XETRA:DEZ
|
0.011x |
Annual Cash Flow Conversion Efficiency for Abbott India Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Abbott India Limited from 2005 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹42.33 Billion | ₹10.12 Billion | 0.239x | -27.10% |
| 2024-03-31 | ₹36.99 Billion | ₹12.13 Billion | 0.328x | +17.02% |
| 2023-03-31 | ₹31.89 Billion | ₹8.93 Billion | 0.280x | -16.63% |
| 2022-03-31 | ₹28.20 Billion | ₹9.48 Billion | 0.336x | +20.33% |
| 2021-03-31 | ₹26.02 Billion | ₹7.27 Billion | 0.279x | +8.47% |
| 2020-03-31 | ₹24.32 Billion | ₹6.26 Billion | 0.257x | +3.61% |
| 2019-03-31 | ₹20.09 Billion | ₹4.99 Billion | 0.248x | +175.47% |
| 2018-03-31 | ₹16.93 Billion | ₹1.53 Billion | 0.090x | -59.27% |
| 2017-03-31 | ₹13.87 Billion | ₹3.07 Billion | 0.222x | +6.50% |
| 2016-03-31 | ₹11.96 Billion | ₹2.49 Billion | 0.208x | -9.21% |
| 2015-03-31 | ₹9.38 Billion | ₹2.15 Billion | 0.229x | +53.60% |
| 2014-03-31 | ₹8.33 Billion | ₹1.24 Billion | 0.149x | -4.81% |
| 2013-03-31 | ₹6.47 Billion | ₹1.01 Billion | 0.157x | +254.26% |
| 2012-03-31 | ₹5.44 Billion | ₹240.66 Million | 0.044x | -70.68% |
| 2011-03-31 | ₹3.05 Billion | ₹460.64 Million | 0.151x | +10.24% |
| 2010-03-31 | ₹2.72 Billion | ₹371.57 Million | 0.137x | -65.29% |
| 2009-03-31 | ₹2.21 Billion | ₹872.13 Million | 0.394x | +196.26% |
| 2008-03-31 | ₹2.31 Billion | ₹307.40 Million | 0.133x | -19.72% |
| 2007-03-31 | ₹2.46 Billion | ₹407.40 Million | 0.166x | -2.57% |
| 2006-03-31 | ₹2.16 Billion | ₹368.20 Million | 0.170x | -53.15% |
| 2005-03-31 | ₹1.88 Billion | ₹683.70 Million | 0.363x | -- |